DUCHENE MUSCULAR DYSTROPHY
Clinical trials for DUCHENE MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new DUCHENE MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for DUCHENE MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for duchenne: new drug targets rare gene mutation in phase 3 trial
Disease control Not yet recruitingThis study tests an experimental drug called AOC 1044 for boys with Duchenne muscular dystrophy (DMD) who have a specific genetic change (exon 44 skipping). About 70 boys aged 7 to 16 who can still walk will receive either the drug or a placebo. The main goal is to see if the dru…
Matched conditions: DUCHENE MUSCULAR DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Exercise hope: new study tests Muscle-Strengthening in kids with DMD
Symptom relief Not yet recruitingThis study will test different types of strengthening exercises in 45 children aged 6 to 10 with Duchenne muscular dystrophy (DMD). The goal is to see if these exercises can improve muscle strength, walking distance, and chemical markers in the blood. The results could help guide…
Matched conditions: DUCHENE MUSCULAR DYSTROPHY
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC